Verma: COVID-19 proving the need for greater interoperability

Seema Verma
Centers for Medicare & Medicaid Services Administrator Seema Verma spoke about the impact COVID-19 is having on interoperability discussions at an event Tuesday. (HIMSS)

The COVID-19 pandemic has “exposed a lot of inefficiencies” in the healthcare system—with one of the largest being data sharing and access, Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma said Tuesday.

Data access is critical both for patients who are navigating care for COVID-19 as well as for the army of contact tracers trying to track the spread of the virus, the CMS chief said while speaking during Fortune’s Brainstorm Health event.

“That data is often trapped in electronic silos,” Verma said.

Featured Webinar

Reducing barriers to patient care: A cross-industry collaboration

Optum will bring together cross-industry experts to share a case study detailing how an employer, provider, payer and pharmaceutical company worked together to address migraines, a hard-to-diagnose condition. Learn how this team started with a model to risk stratify, predict undiagnosed, misdiagnosed and mismanaged members and how those analytics were used to enrich engagement for treatment and diagnosis optimization.

For example, Verma said, the patients who were in quarantine on cruise ships during the early days of the pandemic would have been in a better position if they had access to their electronic health records and medical data, which would provide details on other medical conditions or medications they take.

RELATED: Health Care Service Corp. taps Epic for data exchange platform

Interoperability has been a key focus at CMS under the Trump administration, which has been working to push through regulations aimed at increasing data sharing alongside the Office of the National Coordinator for Health IT.

The pandemic has posed a major hurdle to those efforts, as providers call for more time to implement changes amid surges of the virus—even as federal officials argue that COVID-19 has made a clear case for why these updates are necessary.

Verma said enhanced interoperability is also critical in arming public health workers to conduct the necessary contact tracing to monitor the spread of the virus as the economy opens up. She said investments in this area haven’t been up to snuff.

Greater data sharing has also been key for the administration in distributing necessary supplies, including personal protective equipment, ventilators and medications that are being repurposed to treat COVID-19 such as remdesivir.

RELATED: CMS says it wants to cut red tape for docs. It just created an 'Office of Burden Reduction'

In addition, Verma said the pandemic has clearly opened the floodgates for the use of telehealth—“the genie is out of the bottle,” she said. Virtual and telephonic visits for a variety of care needs have skyrocketed as patients are urged to avoid unnecessary trips to the doctor’s office.

She said moving forward telehealth is likely to play a key role in boosting access to care in rural and underserved communities and will be crucial for behavioral health, as having visits in the home can mitigate some of the stigmas associated with seeking mental health care.

As such, CMS is eyeing ways to make expanding access to telehealth permanent, though the final word in overhauls to Medicare lies with Congress, Verma said.

“It's not a panacea; it’s not going to solve every problem,” she said. “Not everything is going to be able to be addressed by telehealth. But it’s a very powerful tool for medicine.”

Suggested Articles

A New Jersey medical office has filed suit against Cigna, alleging that the insurer failed to pay for diagnostic testing and treatment for COVID-19.

CMS issued new guidance Friday to help states implement the new interoperability policies in Medicaid and CHIP programs.

GoodRx has released its latest list of the most expensive drugs in America, with orphan drugs and therapies for rare conditions topping the ranking.